Blockage of intermediate-conductance-Ca(2+) -activated K(+) channels inhibits progression of human endometrial cancer.
about
TRAM-34, a putatively selective blocker of intermediate-conductance, calcium-activated potassium channels, inhibits cytochrome P450 activityEpigenetic dysregulation of KCa 3.1 channels induces poor prognosis in lung cancer.Tumor-associated macrophage-derived IL-6 and IL-8 enhance invasive activity of LoVo cells induced by PRL-3 in a KCNN4 channel-dependent mannerCalcium-activated potassium channels BK and IK1 are functionally expressed in human gliomas but do not regulate cell proliferation.The intermediate conductance Ca2+-activated K+ channel inhibitor TRAM-34 stimulates proliferation of breast cancer cells via activation of oestrogen receptors.The in vitro and in vivo antitumor effects of clotrimazole on oral squamous cell carcinoma.Inhibition of TRPC6 degradation suppresses ischemic brain damage in rats.Calcium-activated K+ channels increase cell proliferation independent of K+ conductance.High expression of KCa3.1 in patients with clear cell renal carcinoma predicts high metastatic risk and poor survival.The Blockage of KCa3.1 Channel Inhibited Proliferation, Migration and Promoted Apoptosis of Human Hepatocellular Carcinoma CellsTherapeutic potential of KCa3.1 blockers: recent advances and promising trends.Inhibition of SK4 Potassium Channels Suppresses Cell Proliferation, Migration and the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells.KCa3.1: target and marker for cancer, autoimmune disorder and vascular inflammation?Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?Regulation of cell proliferation by intermediate-conductance Ca2+-activated potassium and volume-sensitive chloride channels in mouse mesenchymal stem cells.Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels.Functional cooperation between KCa3.1 and TRPC1 channels in human breast cancer: Role in cell proliferation and patient prognosis.KCNN4 and S100A14 act as predictors of recurrence in optimally debulked patients with serous ovarian cancer.EDHF: an update.miR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma.A three ion channel genes-based signature predicts prognosis of primary glioblastoma patients and reveals a chemotherapy sensitive subtype.Intermediate-Conductance-Ca2-Activated K Channel IKCa1 Is Upregulated and Promotes Cell Proliferation in Cervical CancerCalcium-activated potassium channels - a therapeutic target for modulating nitric oxide in cardiovascular disease?K(+) channels as therapeutic targets in oncology.Roles of ion transport in control of cell motility.Potassium channels in cell cycle and cell proliferation.Ion channels in the endometrium: regulation of endometrial receptivity and embryo implantation.Role of the potassium channel KCa3.1 in diabetic nephropathy.An inhibitor of K+ channels modulates human endometrial tumor-initiating cells.IK channel activation increases tumor growth and induces differential behavioral responses in two breast epithelial cell lines.SK4 channels modulate Ca2+ signalling and cell cycle progression in murine breast cancer.Blockade of KCa3.1 potassium channels protects against cisplatin-induced acute kidney injury.Clotrimazole induces a late G1 cell cycle arrest and sensitizes glioblastoma cells to radiation in vitro.Effects of Intermediate-Conductance Ca(2+)-Activated K(+) Channels on Human Endometrial Carcinoma Cells.ATP-sensitive potassium channels control glioma cells proliferation by regulating ERK activity.KCNN4 channels participate in the EMT induced by PRL-3 in colorectal cancer.Inhibitory effects of blockage of intermediate conductance Ca(2+)-activated K (+) channels on proliferation of hepatocellular carcinoma cells.Dynamic redistribution of calcium sensitive potassium channels (hK(Ca)3.1) in migrating cells.Blockade of T-type Ca(2+) channels inhibits human ovarian cancer cell proliferation.Involvement of Ca2+-activated K+ channel 3.1 in hypoxia-induced pulmonary arterial hypertension and therapeutic effects of TRAM-34 in rats.
P2860
Q28487726-87B7B525-7CB6-4D1E-A77C-9643A4BB5D4AQ30316755-F9B232C1-060C-4319-9043-CC554049CBAFQ33624421-B64052BE-3D95-46F0-A805-9D3330316BD4Q33680449-EE9A0B38-37E6-478D-AF77-16E8269E745DQ33685939-71F20595-5A3A-4B7C-9D00-DAF6765C99DFQ33707165-4426F031-1A42-44A2-B8A6-8B0361ED7B5BQ34162188-34994B7D-510D-4B8D-AA48-EABD45DA6638Q34782159-4412684C-D269-4D6E-9E0E-5899E9DDDB88Q35304761-D5F1AAD6-855A-4BDF-BB6C-75EF0EFF034CQ35739537-7CD788F0-DC79-4F25-9DF9-455FEED0856BQ35944615-764FD31A-5BF3-4051-8BD2-A528245BFD6AQ36001840-AA046816-AA24-4D04-A70E-FF1FAA647FDBQ37118983-2C67EDF1-DE9E-4D89-AAEF-65CE906D7648Q37230725-0901BCCC-1DA4-460F-8F52-24D37E248CBDQ37279069-E7D4F414-3010-46BE-9884-EF0A12CEDB09Q37305118-C988F069-C23D-47C9-BBF3-1F6AB8F3C7CBQ37392731-26346AA1-701F-40CE-B7AC-17EBE1A1370AQ37536735-C97DF0D6-286D-4293-8173-E1A9A9DA6076Q37551123-EF5BDEE8-C554-4410-8A05-1E9621A288D9Q37628996-DCF35AB2-0E54-4C5B-A45A-0E33EB69E3ABQ37688866-55A8BCEC-C653-4EA5-B74A-FAB1F60E1BACQ37712067-297143B0-C1F5-4011-97E0-5B89DBF079BCQ37766237-B2AA3AFF-3D02-4B24-8C04-C9397E7A086EQ37855925-0B8B7DA3-03A8-47AE-864F-9A4FCA76C2E9Q38110508-8AC67403-6F04-461F-866A-0031F28A4F66Q38184978-ADE5FF4B-3D5F-4F6E-AABD-97B409C3C354Q38193011-D15B2FF8-4275-43F1-8378-A643C274AE33Q38223110-C9DD61DB-0F06-4D72-BDC9-C77E3F1220E4Q38502913-3002156A-EACF-437C-AF4E-C8D49C3B2D35Q38707271-BEC8AB92-3E66-4DD8-AB39-E513871A0189Q38756814-F7BB17FA-5876-4769-B175-A5417A77829DQ38830162-B3A304A8-434B-4CD4-B7F5-0DEF3CC8D930Q38914722-67C33DC3-6175-47A6-A997-03A40E94014BQ38917890-7655FB9D-BCA9-4026-AC86-4308D96CD7F4Q39084326-3CE8D9F1-1C36-4899-A360-A82412168D2AQ39168782-07C96B1A-CA08-4FE9-9C7C-2616EDE502C1Q39197761-B0D4E1F5-9948-4EAA-8D45-EFD33B68E0DCQ39564417-C6570CA6-3E82-489B-8D66-FBB5812462D3Q39570492-7BF52208-9858-4FFB-9DDC-0B9CEF9C2C11Q41138956-60C42240-0521-4D18-8B48-0A3A5C9F443C
P2860
Blockage of intermediate-conductance-Ca(2+) -activated K(+) channels inhibits progression of human endometrial cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Blockage of intermediate-conductance-Ca
@nl
Blockage of intermediate-condu ...... n of human endometrial cancer.
@en
type
label
Blockage of intermediate-conductance-Ca
@nl
Blockage of intermediate-condu ...... n of human endometrial cancer.
@en
prefLabel
Blockage of intermediate-conductance-Ca
@nl
Blockage of intermediate-condu ...... n of human endometrial cancer.
@en
P2093
P2860
P356
P1433
P1476
Blockage of intermediate-condu ...... n of human endometrial cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.ONC.1210308
P407
P577
2007-02-19T00:00:00Z